Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
Int J Neurosci
    July 2021
    Understanding Visual-Spatial Perceptual Deficits in Individuals with Multiple Sclerosis: An Analysis of Patient Performance on the Hooper Visual Organization Test and Visual Form Discrimination.
    Int J Neurosci. 2021 Jul 13:1-9. doi: 10.1080/00207454.2021.1954642.
    >> Share

    February 2021
  2. DOSKAS T, Vavougios DG, Karampetsou P, Kormas C, et al
    Neurocognitive Impairment and Social Cognition in Multiple Sclerosis.
    Int J Neurosci. 2021 Feb 2:1-26. doi: 10.1080/00207454.2021.1879066.
    >> Share

    January 2021
  3. YAZDANPANAH M, Jalilian N, Abdollah Zadeh R, Sahraian MA, et al
    Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population.
    Int J Neurosci. 2021 Jan 24:1-6. doi: 10.1080/00207454.2020.1860964.
    >> Share

    October 2020
  4. JANKOVSKA E, Lipcseyova D, Svrdlikova M, Pavelcova M, et al
    Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
    Int J Neurosci. 2020 Oct 15:1-17. doi: 10.1080/00207454.2020.1837801.
    >> Share

  5. BATUM M, Kisabay Ak A, Cetin G, Celebi HBG, et al
    Coincidental Occurance of Episodic Ataxia and Multiple Sclerosis: A Case Report and Review of the Literature.
    Int J Neurosci. 2020 Oct 12:1-7. doi: 10.1080/00207454.2020.1835896.
    >> Share

    September 2020
  6. SURMELI R, Surmeli M, Yalcin AD, Sahin Yilmaz AA, et al
    Multiple Sclerosis Attack Case Presenting with Pseudo-Vestibular Neuritis.
    Int J Neurosci. 2020 Sep 28:1-5. doi: 10.1080/00207454.2020.1829617.
    >> Share

  7. NAJAFI S, Beladi Moghadam N, Saadat P, Noorbakhsh SM, et al
    A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
    Int J Neurosci. 2020 Sep 2:1-12. doi: 10.1080/00207454.2020.1818741.
    >> Share

    August 2020
  8. LABIB DA, Ashmawy I, Elmazny A, Helmy H, et al
    Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients.
    Int J Neurosci. 2020 Aug 26:1-5. doi: 10.1080/00207454.2020.1812601.
    >> Share

  9. ANDALORO A, Russo M, Pastura C, Sessa E, et al
    Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
    Int J Neurosci. 2020 Aug 7:1-13. doi: 10.1080/00207454.2020.1807980.
    >> Share

    June 2020
  10. BRAUN T, Juenemann M, Dornes K, El-Shazly J, et al
    BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
    Int J Neurosci. 2020 Jun 30:1-6. doi: 10.1080/00207454.2020.1784167.
    >> Share

  11. ORTIZ GG, Mireles-Ramirez MA, Pacheco-Moises FP, Ramirez-Jirano LJ, et al
    Are Electrophysiological and Oligodendrocyte Alterations an Element in the Development of Multiple Sclerosis at the Same Time as or Before the Immune Response?
    Int J Neurosci. 2020 Jun 22:1-15. doi: 10.1080/00207454.2020.1786087.
    >> Share

    April 2020
  12. MOUSAVI-SHIRAZI-FARD Z, Mazloom Z, Izadi S, Fararouei M, et al
    The effects of modified anti-inflammatory diet on fatigue, quality of life,and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: A randomized clinical trial.
    Int J Neurosci. 2020 Apr 6:1-12. doi: 10.1080/00207454.2020.1750398.
    >> Share

    February 2020
  13. JAMEBOZORGI K, Rostami D, Pormasoumi H, Taghizadeh E, et al
    Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Int J Neurosci. 2020 Feb 20:1-15. doi: 10.1080/00207454.2020.1732974.
    >> Share

  14. MEUTH SG, Henze T, Essner U, Trompke C, et al
    Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
    Int J Neurosci. 2020 Feb 17:1-15. doi: 10.1080/00207454.2020.1730832.
    >> Share

    December 2019
  15. JAFARINIA M, Sadeghi E, Alsahebfosoul F, Etemadifar M, et al
    Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Int J Neurosci. 2019 Dec 3:1-6. doi: 10.1080/00207454.2019.1694925.
    >> Share

  16. SHAKER OG, Golam RM, Ayoub S, Daker LI, et al
    Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
    Int J Neurosci. 2019 Dec 2:1-7. doi: 10.1080/00207454.2019.1695610.
    >> Share

  17. RAJIZADEH MA, Sheibani V, Bejeshk MA, Mohtashami Borzadaran F, et al
    The effects of high intensity exercise on learning and memory impairments followed by combination of sleep deprivation and demyelination induced by etidium bromide.
    Int J Neurosci. 2019;129:1166-1178.
    >> Share

    November 2019
  18. MORADI M, Gharesouran J, Ghafouri-Fard S, Noroozi R, et al
    Role of NR3C1 and GAS5 genes polymorphisms in Multiple Sclerosis.
    Int J Neurosci. 2019 Nov 14:1-10. doi: 10.1080/00207454.2019.1694019.
    >> Share

    October 2019
    Towards a Comprehensive Etiopathogenetic and Pathophysiological Theory of Multiple Sclerosis.
    Int J Neurosci. 2019 Oct 7:1-41. doi: 10.1080/00207454.2019.1677648.
    >> Share

    September 2019
  20. EFTEKHARIAN MM, Taheri M, Arsang-Jang S, Komaki A, et al
    Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.
    Int J Neurosci. 2019 Sep 2:1-5. doi: 10.1080/00207454.2019.1660655.
    >> Share

    March 2019
  21. HALICIOGLU S, Turkoglu SA
    Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases.
    Int J Neurosci. 2019;129:245-251.
    >> Share

    January 2019
  22. DOGAN U, Ulas F, Aydin Turkoglu S, Nur Ogun M, et al
    Eyes are Mirror of the Brain: Comparison of Multiple Sclerosis Patients and Healthy Controls Using OCT.
    Int J Neurosci. 2019 Jan 29:1-9. doi: 10.1080/00207454.2019.1576660.
    >> Share

    October 2018
  23. SHAHEEN HA, Sayed SS, Daker LI, AbdelAziz HE, et al
    Does vitamin D deficiency predict early conversion of clinically isolated syndrome? A preliminary Egyptian study.
    Int J Neurosci. 2018;128:946-951.
    >> Share

    August 2018
  24. JAHANBANI-ARDAKANI H, Alsahebfosoul F, Moshfeghi SR, Mahaki B, et al
    Serum level of Interleukin 12 in patients with multiple sclerosis.
    Int J Neurosci. 2018 Aug 8:1-7. doi: 10.1080/00207454.2018.1504782.
    >> Share

    May 2018
  25. MARKOVA J, Essner U, Akmaz B, Marinelli M, et al
    Sativex(R) as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
    Int J Neurosci. 2018 May 24:1-26. doi: 10.1080/00207454.2018.1481066.
    >> Share

    January 2018
  26. FAHMY EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, et al
    Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.
    Int J Neurosci. 2018 Jan 31:1-23. doi: 10.1080/00207454.2018.1435538.
    >> Share

  27. LI LM, Guo HY, Zhao N, Zhang LJ, et al
    Comparison of olfactory function between neuromyelitis optica and multiple sclerosis.
    Int J Neurosci. 2018 Jan 3:1-21. doi: 10.1080/00207454.2018.1424152.
    >> Share

    October 2017
  28. ABDOLLAH ZADEH R, Moradi Pordanjani P, Rahmani F, Mashayekhi F, et al
    Association of VDR gene polymorphisms with risk of Relapsing-remitting multiple sclerosis in an Iranian Kurdish population.
    Int J Neurosci. 2017 Oct 26:1-17. doi: 10.1080/00207454.2017.1398158.
    >> Share

    January 2017
  29. KIM G, Chu R, Yousuf F, Tauhid S, et al
    Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Int J Neurosci. 2017 Jan 19:1-34. doi: 10.1080/00207454.2017.1283313.
    >> Share

    December 2016
  30. DAHDALEH M, Alroughani R, Aljumah M, AlTahan A, et al
    Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
    Int J Neurosci. 2016 Dec 28:1-16. doi: 10.1080/00207454.2016.1277424.
    >> Share

  31. LASEK-BAL A, Bartoszek K, Steposz A, Puz P, et al
    Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.
    Int J Neurosci. 2016.
    >> Share

    November 2016
  32. GAO C, Wu L, Chen X, Long Y, et al
    Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
    Int J Neurosci. 2016;126:1036-43.
    >> Share

    September 2016
  33. JAMROZ-WISNIEWSKA A, Beltowski J, Bartosik-Psujek H, Wojcicka G, et al
    Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Int J Neurosci. 2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016